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Sexual dimorphism in myocardial
acylcarnitine and triglyceride metabolism
Sriram Devanathan1†, Timothy D. Whitehead1†, Nicole Fettig1, Robert J. Gropler1,2, Samuel Nemanich1
and Kooresh I. Shoghi1,3,4*
Abstract
Background: Cardiovascular disease is the leading cause of death among diabetic patients. Importantly, recent
data highlight the apparent sexual dimorphism in the pathogenesis of cardiovascular disease in diabetics with
respect to both frequency- and age-related risk factors. The disposition to cardiovascular disease among diabetic
patients has been attributed, at least in part, to excess lipid supply to the heart culminating in lipotoxicity of the
heart and downstream derangements. A confounding factor in obese animal models of diabetes is that increased
peripheral lipid availability to the heart can induce cardio-metabolic remodeling independent of the underlying
pathophysiology of diabetes, thus masking the diabetic phenotype. To that end, we hypothesized that the use of
non-obese diabetic (NOD) animal models will reveal metabolic signatures of diabetes in a sex-specific manner.
Methods: To test this hypothesis, male and female NOD Goto-Kakizaki (GK) rats were used to assess the expression
profile of 84 genes involved in lipid metabolism. In parallel, targeted lipidomics analysis was performed to characterize
sex differences in homeostasis of non-esterified fatty acids (NEFA), acylcarnitines (AC), and triglycerides (TG).
Results: Our analysis revealed significant sex differences in the expression of a broad range of genes involved in
transport, activation, and utilization of lipids. Furthermore, NOD male rats exhibited enhanced oxidative metabolism
and accumulation of TG, whereas female NOD rats exhibited reduced TG content coupled with accumulation of AC
species. Multi-dimensional statistical analysis identified saturated AC16:0, AC18:0, and AC20:0 as dominant metabolites
in mediating sex differences in AC metabolism. Confocal microscopy of rat cardiomyocytes exposed to AC14:0, AC16:0,
and AC18:0 confirmed induction of ROS with AC18:0 being more potent followed by AC14:0.
Conclusion: Overall, we demonstrate sex differences in myocardial AC and TG metabolism with implications for
therapy and diagnosis of diabetic cardiovascular disease.
Keywords: Sex differences, Lipid metabolism, Acylcarnitines, Triglycerides, NEFA, Type 2 diabetes, Non-obese,
Lipidomics, Genomics, Cardiac metabolism, Biomarker, ROS
Background
Heart disease is the leading cause of death among dia-
betic patients, independent of macro- and micro- vascu-
lar diseases [1–3]. While diabetes increases the risk of
cardiovascular disease in both males and females, recent
data suggests that heart disease is fivefold more common
in diabetic women compared with twofold in men [4].
For example, in the setting of myocardial infarction, dia-
betic women have a greater progression to heart failure
and poorer outcome compared with diabetic males [5].
This “sexual dimorphism” is in contrast to the estab-
lished notion of a “female advantage” in that premeno-
pausal women in general are better protected from most
common forms of cardiovascular disease compared to
men [4, 6–9]. Thus, T2DM nullifies the female advan-
tage in the prevalence of cardiovascular disease [4, 10].
Multiple lines of evidence suggest that the predispos-
ition to heart failure among diabetic patients is a conse-
quence of severe alterations in myocardial substrate
metabolism [11, 12]. In particular, insulin resistance
shifts the balance of substrate utilization such that the
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diabetic heart relies almost exclusively on fatty acids
(FAs) for its energy needs [13]. The increased reliance
on FA oxidation competes with glucose oxidation fur-
ther exacerbating deficiencies in insulin signaling [14].
Excess lipid supply beyond the oxidative capacity of the
heart results in accumulation of triglycerides (TG) and
lipid intermediates, leading to lipotoxicity of the heart
and downstream derangements, including generation of
reactive oxygen species (ROS), inflammation, and cell
death [15–20].
On the one hand, the observed sexual dimorphism
may be explained by the higher systemic availability of
lipids [21, 22] resulting in increased myocardial FA me-
tabolism. Indeed, it is well established that females have
higher distribution of visceral fat with higher levels of
circulating FA and TGs [22]. As an omnivore, the heart
will necessarily utilize circulating substrates in propor-
tion to their availability in blood. To that end, in vivo
metabolic imaging studies in diabetic humans have dem-
onstrated that, in fact, female hearts exhibit higher flux
of FAs compared to age-matched males [23, 24], attrib-
uted to higher systemic availability of FA. On the other
hand, however, there may be intrinsic sex differences in
cardiac lipid metabolism beyond increased peripheral
supply of lipids to the heart that may account for the
sexual dimorphism. One confounding factor in obese
and dietary animal models of diabetes is that increased
peripheral lipid availability to the heart can induce
cardio-metabolic remodeling independent of the under-
lying pathophysiology of diabetes, thus masking the dia-
betic phenotype. In this regard, it is worth noting that,
in fact, 20 % of the population is non-obese diabetic
(NOD) [25, 26]. This suggests that studies utilizing
NOD humans and/or non-obese animal models of dia-
betes may unmask mechanisms relevant to pathophysi-
ology of diabetes.
In this work, we sought to determine whether
there are intrinsic sex differences in myocardial FA
metabolism in the setting of diabetes, independent of
systemic effects seen in obesity or dietary animal
models of diabetes. We previously demonstrated that
NOD Goto-Kakizaki (GK) rats exhibit a genomic dis-
position to increased FA metabolism [27]. We hy-
pothesized that utilizing both sexes of this model
will reveal metabolic signatures of diabetes inde-
pendent of obesity, in a sex-specific manner. Quanti-
tative expression profiling of genes involved in FA,
acylcarnitines (AC), and TG metabolism as well as
targeted lipidomic profiling on cardiac tissue extracts
was performed to characterize genomic-metabolic
variations between the groups. Finally, multi-
dimensional statistical analysis was performed to
identify and confirm signatures of sex differences in
metabolism that can induce ROS.
Methods
Animal model and study design
All experiments were conducted according to the proto-
col approved by the animal experiment committee at
Washington University School of Medicine at Saint
Louis (IACUC Animal Welfare Assurance # A-3381-01).
NOD and Wistar rats (Charles River, USA) were main-
tained under standard housing conditions and fed with
commercial pelleted chow (Harlan, USA) until ready for
the study at age of 24 weeks. A balanced factorial design
at two levels was used to investigate sex and phenotype
differences and possible interactions between these two
factors. The following four animal groups were tested:
(1) Wistar male, (2) Wistar female, (3) GK male, and (4)
GK female with N = 4–6 per group. Blood samples were
taken via the tail vein from anesthetized animals
(overnight fast, typically 10 h) in each group and im-
mediately centrifuged. The serum fractions were
assayed for TG, non-esterified fatty acids (NEFA), glu-
cose, and insulin levels. All animals were sacrificed at
the end of the study, and their hearts were snap-
frozen for subsequent analyses. Lipidomic analysis
was performed on individual tissue extracts (N = 6 per
group), while gene expression studies was performed
on representative samples (N = 4 per group), randomly
chosen from each group. FA and TG were extracted
from 100 mg of pulverized cardiac tissue samples
using a chloroform/methanol mixture. Commercial
kits for FA (Wako Diagnostics, VA) and TG analyses
(Infinity Triglycerides Reagent, Thermo Scientific,
USA) were used for both plasma and tissue samples.
RNA isolation and real-time RT-PCR
Quantitative real-time RT-PCR (qPCR) was performed
as described previously [27]. The RNeasy lipid tissue ex-
traction kit (Qiagen, MD) was used to extract total RNA
from pulverized heart tissue. RNA concentration, purity,
and integrity were determined by spectrophotometric
analysis and Agilent Bio-analyzer. qPCR was conducted
in a 384-well plate array format for 84 genes involved in
FA metabolism (Cat No: PARN- 0007E, SA Biosciences,
MD). From the panel of housekeeping genes, lactate de-
hydrogenase A (ldhA) was chosen for normalizing the
data as it displayed no variation among test groups. For
assessing ROS response in AC-treated cardiomyocytes,
PrimeTime® primers for Sod1, Sod2, and Cat were
sourced from IDT DNA technologies (Coralville, IA).
Mass spectrometric detection of NEFAs, ACs, and TGs
Mass spectrometric analysis was performed at the Dia-
betic Cardiovascular Disease Center (DCDC) Lipidomics
Core Facility using established methodology. Briefly, a
modified Bligh-Dyer extraction [28] was used to extract
NEFAs and TGs, and a protein precipitation method
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was used to extract ACs from the heart homogenates in
the presence of internal standards (d4-NEFA16:0,
TG17:1-17:1-17:1, and d3-AC16:0). To improve the sen-
sitivity of MS, NEFAs were derivatized with dimethyla-
minopropylamine, dimethylaminopyridine, and 1-ethyl-
3-[3-dimethylaminopropyl] carbodiimide hydrochloride
into amides, and ACs were derivatized with methanol
and acetyl chloride into methyl esters. Sample analysis
was performed with a Shimadzu 10A HPLC system
coupled to a TSQ Quantum Ultra triple quadrupole
mass spectrometer operated in SRM mode under ESI(+).
Echocardiography
Echocardiography was performed using non-invasive
ultrasound imaging with the Vevo2100 Ultrasound Sys-
tem (Visual Sonics Inc., Toronto, ON, Canada) at ages
23–24 weeks as described previously [29]. Briefly, rats
were anesthetized with 1 % Isoflurane and secured to
the imaging platform. Complete two-dimensional, M-
mode, and Doppler examinations using a 21-MHz trans-
ducer were performed to quantify left ventricular struc-
ture as well as diastolic and systolic function. To
account for differences in body weight, all of the struc-
tural dimensions were indexed to body weight.
Confocal microscopy to assess induction of ROS by ACs
Immortalized neonatal rat cardiomyocytes were obtained
from Applied Biological Materials, Inc. Canada (Catalog
No. T0015) and maintained in PriGrow III media (ABM
Good, Canada). The method for microscopic determin-
ation of ROS has been described previously [30, 31] and
was used here with minor modifications appropriate for
this study. Briefly, cells were seeded at 1 × 105 per 35-
mm glass-bottomed μdish (Catalog no. 81158 iBidi,
Germany) and incubated overnight. The cells were
serum starved for 8 h and then treated with 10 μM CM-
H2DCFDA (Molecular Probes, C6827), a chloromethyl
(CM) derivative of H2DCFDA, in PBS at 37 °C for
30 min. The treatment was followed by two quick
washes using ice cold PBS. Based on previous work [30],
cells were incubated with 25 μM of each of the following
ACs for 3 h at 37 °C: palmitoyl-L-carnitine (AC16:0)
(P1645, Sigma-Aldrich), stearoyl-L-carnitine (AC18:0)
(50494231, Fisher Scientific), and myristoyl-L-carnitine
(AC14:0) (41570, Crystal Chem, IL). The 3-h incubation
period was selected to remain within the stability range
of the fluorophore per manufacturer’s recommendation.
Cells were then examined using a Nikon A1Rsi + laser
scanning confocal microscope at ×40 magnification
using laser excitation at 488 and emission 543 nm at the
Bakewell Neuroimaging Laboratory at Washington Uni-
versity. ROIs were defined using NIS-Elements (Nikon,
USA) on 30–35 images by filtering background and sat-
urated intensities as well as filtering for objects/debris
that were less than 5 μm in size as rat cardiomyocytes
are at least 10 μm in size [32]. The sum intensity of
ROIs for each image from the test groups were com-
pared with the control by t test.
Data and statistical analysis
All data sets from the two level factorial designs were
first examined to verify equal variance among test
groups using residual analysis, and if necessary, the data
were log2 transformed. The data were analyzed using a
two-way ANOVA with interaction model (sex, pheno-
type, sex*phenotype). ANOVA was followed with group
contrast comparisons using Fisher’s least squares differ-
ence to determine significance. Student’s t test was used
to determine significant statistical differences in fluores-
cence intensities obtained from our microscopic analysis
of genes Sod1, Sod2, and Cat between control and AC-
treated groups.
Sex differences in the distribution of lipid species
We also sought to assess whether the fraction (as per-
cent) of species enriched/depleted in each lipid category
(i.e., FA, TG, and AC) was significantly different within
and between sexes. This analysis ignored the statistical
findings of the ANOVA for individual species; rather, the
number of species enriched or depleted in the respective
category was counted. The significance of the overall
fold change in the number of species enriched or de-
pleted (GK to Wistar) profile was determined by com-
paring to a binomial distribution with the assumption
that if the variable had no effect, then the number of
species enriched or depleted would be random with a bi-
nomial distribution with mean = 0.5.
Sex differences in metabolic pathways
Genes were categorized into the metabolic functional
groups. Because the interpretation of the ANOVA inter-
action term for the genes was more nuanced than for
the metabolites (i.e., many interactions were due to dif-
ferences in magnitude rather than just sign), a rank-sum
test, which considers both sign and magnitude, was used
to determine significant differences in metabolic path-
ways between the sexes. The GK/Wistar fold change
sign and magnitude was used as the test parameter and
sex was the categorical variable. The data were analyzed
for low-expressing genes using a criterion that the Ct
count must not be greater than 2 standard deviations
from the average of all genes. Therefore, any gene with a
Ct count >28 was considered non-expressing.
Principal component analysis
Principal component analysis (PCA) was performed on
the gene and metabolite data separately using the correl-
ation matrix of the standardized data. Only those genes
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or metabolites that had at least one significant contrast
comparison in the ANOVA analysis were included in
the PCA. As in above, low-expressing genes were omit-
ted from the analysis. Radar plots were used to present
the PCA results. Partek Genomics Suite (St. Louis, MO)
was used for ANOVA, STATA (College Station, TX) for
the binomial distribution tests, and JMP Genomics for
the PCA. The data are presented as mean ± standard
error of the mean (SEM) and a P value ≤0.05 was con-
sidered significant. While the statistics may have been
performed on transformed data, the results are graphed
in their original metric as a convenience to the reader.
Results
Baseline characteristics
We found no significant differences in serum FA level
among the four groups. Serum TG levels were signifi-
cantly elevated in NOD rats with males and females
exhibiting 1.38- and 2.2-fold increase over correspond-
ing Wistar rats, respectively (Table 1). Overall, these
baseline characteristics are in agreement with previous
reports on GK rats [33, 34].
Echocardiograph: anatomical and functional parameters
Weight-indexed measures of LVPW, LVID, and LVM
were significantly higher in NOD rats compared to cor-
responding Wistar control rats (Table 2). Functionally,
NOD rats exhibited a significant reduction in parameters
of early component mitral annular diastolic motion (E′)
and LV filling velocity in the atrial component (A) com-
pared to Wistars, as well as both phenotypic and sex dif-
ferences in early left ventricular filling velocity (E)
(Table 2).
Sex differences in expression profile of genes involved in
lipid metabolism
Figure 1a summarizes the ANOVA results for the differ-
ential expression of genes categorized by their metabolic
functionality. The number of genes modulated between
NOD and Wistar by sex is shown for each functional
group. Overall, the pathway analysis indicates a signifi-
cant increase in the expression of genes involved in
beta-oxidation in NOD male rats relative to female rats,
concomitant with reduced expression of genes involved
FA activation and AC metabolism in NOD female rats.
Other significant sex differences in pathway expression
include intracellular FA trafficking and triacylglycerol
metabolism. To characterize which genes dominate the
variance among the groups, we performed PCA to re-
duce the dimensionality of the data.
Figure 1b depicts the segregation of the four test
groups by PCA. The first three principal components
(PCs) accounted for 85 % of the variability. Figure 1c is a
radar plot of absolute gene loading values greater than
0.5 for each PCs. The genes were sorted by decreasing
order of the absolute magnitude of their primary compo-
nent. The PCs are associated with general fold change
patterns that can be discerned from examination of
Additional file 1: Table S1. PC1 accounts for 57.4 % of
the variation in the data and is associated with genes
that exhibit sex differences and a significant interaction
term in the ANOVA model. Those genes with a positive
PC1 value (PC1pos) are downregulated in females com-
pared to males, while those with a negative value
(PC1neg) are upregulated in females. Further, the inter-
action is far more prevalent in genes associated with
PC1neg in that the sex difference fold changes are
higher in Wistar than in the NOD phenotype. Generally,
genes associated with PC2(+) are elevated in NOD rats,
while those with PC2(−) are lower in NOD rats. PC3 has
too few genes to ascribe a pattern. Overall, the loading
values can be used to correlate the contribution of a
gene/pathway to the overall phenotype of sex differences
in metabolism.
Sex differences in NEFA homeostasis
The enrichment profile of NEFAs obtained by LC-MS/
MS is summarized in Fig. 2a (Additional file 2: Figure S1
depicts male and female data separately). Our results re-
veal that of the NEFAs profiled, every measured NEFA
Table 1 Baseline measurements
Male Female ANOVA
Wistar GK Wistar GK Phenotype Sex Phen × sex
(N = 4) (N = 4) (N = 4) (N = 4)
Weight (g) 491.67 ± 5.34 334.17 ± 10.26* 256.97 ± 5.35 230 ± 2.80‡ <0.001 <0.001 <0.001
Insulin (μU/mL) 14.5 ± 5.76 12.33 ± 2.00 11.86 ± 3.56 7.46 1.37 0.199 0.348 0.362
Glucose (mmol/L) 7.80 ± 0.43 9.85 ± 0.54† 7.68 ± 0.57 9.76 ± 1.25† 0.020 .0936 0.745
Serum NEFA (μmol/L) 1084.50 ± 155.94 1434.25 ± 124.64 1421.75 ± 202.11 1406.25 ± 130.01 0.305 0.341 0.265
Serum TG (μmol/L) 877.01 ± 155.69 1219.97 ± 119.37‡ 525.78 ± 88.95 1157.80 ± 244.44‡ 0.011 0.228 0.392
Tissue NEFA (μg/mg) 0.77 ± 0.03 1.34 ± 0.18† 0.74 ± 0.04 0.98 ± 0.06 0.0005 0.071 1
Values are mean ± SEM. Italicized values indicate significance at P < 0.05, †P < 0.05, ‡P < 0.01, *P < 0.001 GK significantly different than Wistars
GK Goto-Kakizaki rats
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species is significantly enriched in male NOD rats com-
pared to male Wistar rats in agreement with overall tis-
sue NEFA concentration summarized in Table 1. In
females, however, only NEFAs 20:1 and 22:1 are signifi-
cantly depleted in NOD, while NEFAs 20:3 and 22:4 are
significantly enriched in NODs. Based on the binomial
distribution analysis, there is a significant sex difference
in the distribution of NEFAs with male NOD exhibiting
significant enrichment of lipid species (Fig. 2b). The data
in Fig. 2c suggests that the concentration of both long
Table 2 Echocardiograph measurements
Male Female ANOVA
Parameter Wistar GK Wistar GK Phenotype Sex Phenotype × sex
HR (bpm) 396.22 ± 16.90 345.56 ± 27.34* 388.13 ± 16.36 324.67 ± 25.41‡ <0.001 0.343 0.67
LVPWId (μm/g) 0.0037 ± 0.0003 0.0049 ± 0.0005 0.0046 ± 0.0003 0.0063 ± 0.0002 <0.0005 <0.0005 0.31
LVPWIs (μm/g) 0.0060 ± 0.0003 0.0073 ± 0.0006† 0.0083 ± 0.0005 0.0102 ± 0.0008 <0.0005 <0.0005 0.49
LVIDId (μm/g) 0.0150 ± 0.001 0.0219 ± 0.001 0.0240 ± 0.001 0.0291 ± 0.001‡ <0.0005 <0.0005 0.35
LVIDIs (μm/g) 0.0087 ± 0.0007 0.0136 ± 0.0013 0.0120 ± 0.0013 0.0170 ± 0.0009 <0.0005 <0.0005 0.82
LVMI (mg/g) 2.45 ± 0.15 2.84 ± 0.18* 2.52 ± 0.10 3.04 ± 0.19* <0.0005 0.23 0.54
FS (%) 43.45 ± 1.78 38.20 ± 4.44 48.52 ± 3.91 41.57 ± 3.45 <0.05 0.092 0.728
E (mm/s) 1041.33 ± 82.04 818.50 ± 39.05* 838.67 ± 49.27 750.57 ± 48.21* <0.01 <0.01 0.161
E′ (mm/s) 54.43 ± 8.10 36.26 ± 6.77* 44.65 ± 3.23 30.04 ± 5.51‡ <0.01 0.124 0.725
A (mm/s) 813.67 ± 76.65 560.50 ± 38.94* 727.50 ± 57.27 535.43 ± 48.99‡ <0.0005 0.257 0.528
A′ (mm/s) 51.35 ± 6.4 52.27 ± 5.97 62.67 ± 5.71 55.24 ± 6.07 0.527 0.173 0.419
Values are mean ± SEM. Italicized values indicate significance at P < 0.05. *P < 0.05, ‡P < 0.01, †P < 0.001 GK significantly different than Wistars
GK Goto-Kakizaki rats, HR heart rate, LVPWId and LVPWIs left ventricle posterior wall index during diastole and systole, respectively, LVIDId and LVIDIs left ventricle
internal dimension index during diastole and systole, respectively, LVMI Left ventricle mass index as measure of cardiac structural parameters, FS fractional
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Fig. 1 Sex differences in expression profile of genes involved in lipid metabolism. a Number of genes modulated between NOD and Wistar rats
by sex from ANOVA model. A section sign (§) indicates that pathways differ between sexes by the rank-sum test (P ≤ 0.05). b 3D score plot of first
three principal components (PCs) for genes from principal component analysis. c Shows the radar plot of loading factors of PCs for gene analysis.
The purple line and circles represent PC1, the brown line and circles represent PC2, and green line and circles represent PC3. While absolute loading
values are used to plot, the closed and open circles represent (+) and (–) loading values, respectively. P < 0.05 is the significance level for all tests
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and very long NEFAs is higher in NOD compared to
Wistar rats, but the differences only reach statistical sig-
nificance in males. Analysis of NEFA profile based on
degree of saturation reveals that saturated, mono-, and
poly-unsaturated fatty acids accumulate to a higher ex-
tent in NOD compared with Wistar rats, but the differ-
ences are only significant in males (Fig. 2d).
Furthermore, NOD rats overall exhibit significant accu-
mulation of mono- and poly-unsaturated fatty acids
compared to Wistar rats.
Sex differences in TG homeostasis
Analysis of the individual TG species levels by LC-MS/
MS indicates that all measured TG species were de-
pleted in NOD females compared to Wistar females
(Fig. 3a) (Additional file 3: Figure S2 depicts male and
female data separately). Moreover, the binomial distribu-
tion analysis suggests that the number of species de-
pleted in females was statistically significant, compared
to males (see “Methods” section) (Fig. 3b). Consistent
with these data, the spectrophotometric analysis of total
TG in cardiac tissue suggests that female NOD rats
exhibited significantly reduced TG concentrations than
the Wistar female, while male NOD rats exhibited a
higher average TG content. Although the difference in
males is not significant, the significant interaction sug-
gests that the differences in total TG accumulation be-
tween NOD and Wistar rats differs significantly in males
and females (Fig. 3c).
Sex differences in AC homeostasis
The LC-MS/MS metabolic profile of ACs revealed sig-
nificant sex differences in the ACs profiled (Fig. 4a)
(Additional file 4: Figure S3 depicts male and female
data separately). Moreover, our data suggests sex differ-
ences in abundance of ACs with female rats exhibiting
significantly higher abundance of AC (Fig. 4b) and spe-
cies (Fig. 4c) compared to male rats. Since tissue ACs
are elevated in female rats, we sought to determine
whether differences in serum TG or NEFA levels could
account for the higher AC levels in tissue. To test this
possibility, we normalized the AC concentration to the
sum of the serum TG and NEFA concentrations for each






















































































































































































Fig. 2 Sex differences in NEFA homeostasis. a Profile of NEFA in cardiac tissue, as measured by LC-MS/MS, presented as fold change between NOD and
Wistar rats by sex. An asterisk (*) indicates that the fold change is statistically significant. A section sign (§) indicates that the ANOVA interaction term is
significant, and therefore, the fold changes in males and females also are. A dagger (†) indicates that in the ANOVA model, the overall sex difference is
statistically significant. b Distribution of enriched and depleted of NEFA moities. The asterisk (*) indicates that the distribution is significantly different than a
binomial distribution with mean = 0.5. The dagger (†) indicates that the distribution in males and females differ significantly. c, d The distribution of FAs
based on their chain-length and degree of saturation, respectively. Data is presented as mean ± SEM (N= 6). An asterisk (*) indicates that the difference in
adjacent bars is statistically significant. A section sign (§) indicates that the ANOVA interaction term is significant. P< 0.05 is the significance level for all tests
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Our data (not shown) indicate sex differences in AC
levels independent of serum TG and NEFA. Thus, the
elevated serum levels cannot sufficiently account for the
increased AC levels in female.
The AC concentration data was binned by medium,
long, and very long chains, and the results plotted in
Fig. 4d. The results indicate that AC concentrations are
lower in males for all chain lengths and that for the
medium chain lengths, the concentrations are statisti-
cally lower in NOD females than in Wistar females.
These observations are consistent with the information
in Fig. 4a, b. It is also observed from Fig. 4a that, for the
short chain AC, 4/4 are elevated in females in Wistar
rats, while only the longest of the short chain AC is sta-
tistically elevated in NOD females compared to males.
In the long chain AC, however, 5/10 are statistically
higher in female compared to male NOD rats, while only
1/10 is statistically higher in Wistar rats. Finally, parti-
tioning of AC by degree of saturation suggests that fe-
male rats exhibit higher levels of saturated and mono-
unsaturated AC (Fig. 4e).
Integrated lipidomics analysis of NEFA, AC, and TG
Figure 5a reveals the segregation of the lipidomics data
among the four test groups based on PCA analysis.
Figure 5b summarizes the results of the PCA and is a
radar plot of absolute gene loading values greater than
0.5 for each PC. The general fold change pattern associ-
ated with each PC can be discerned from examination of
Additional file 5: Table S2. PC1 accounts for 52.4 % of
the variation in the data and is associated almost exclu-
sively with TG that are elevated in female Wistar over
male Wistars. There are two AC associated with PC1,
and both are elevated in females irrespective of pheno-
type. There are also three NEFAs associated with PC1
that exhibit interactions both with respect to female vs
male by phenotype and GK vs Wistar by sex.
PC2 accounts for 20.7 % of the variation and is as-
sociated primarily with NEFA. PC2 species also have
significant interaction terms in their ANOVA models.
NEFA are elevated in females among Wistar rats but
are depleted in females among NOD rats. Among
males, NEFA are elevated in NOD rats, while gener-
ally the same among females. PC3 is composed
primarily of ACs, which are elevated in females irre-
spective of phenotype. One AC, 22:4, is also elevated
in NOD over Wistar overall. PC4 is also exclusively
AC of 20 carbon length but differs from PC3 in that
the interaction term is significant in the ANOVA
































































































































































































































































































































































Fig. 3 Sex differences in TG homeostasis. a Profile of TG species in cardiac tissue, as measured by LC-MS/MS, presented as fold change between NOD and
Wistar rats by sex. An asterisk (*) indicates that the fold change is statistically significant. A section sign (§) indicates that the ANOVA interaction term is
significant, and therefore, the fold changes in males and females are also significant. A dagger (†) indicates that in the ANOVA model, the overall sex
difference is statistically significant. b Distribution of enriched and depleted of TG moities. The asterisk (*) indicates that the distribution is significantly
different than a binomial distribution with mean = 0.5. The dagger (†) indicates that the distribution in males and females differ significantly. c The total
amount of TG present in the cardiac tissue as measured by spectrophotometric analysis, mean ± SEM (N= 6). P< 0.05 is the significance level for all tests
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rats but is unchanged with sex in Wistar, and it is de-
pleted in NOD among male rats.
Of the FA examined, PCA identified FA 18:1, 20:3, and
22:4 as having the most influence in dictating sex differ-
ences in FA metabolism, whereas AC16:0 and AC18:0 in
PC3 as well as AC20:0 in PC4 were identified as contrib-
uting to sex differences in AC metabolism (Fig. 5b). To
test the feasibility of the former set of ACs to induce
ROS, cardiomyocytes were exposed to 25 μM of each
AC14:0, AC16:0, and AC18:0 ACs. Quantitative analysis
of confocal microscopy images (Fig. 5c) suggests that the
relative efficiency of ROS induction was AC18:0 >
AC14:0 > AC16:0 (Fig. 5d). Accordingly, the expression
levels of Sod1, Sod2, and Cat genes encoding for key
enzymes involved in ROS scavenging were significantly
higher in AC-treated cardiomyocytes (Fig. 5e). In agree-
ment with quantitative confocal microscopy images, the
magnitude of differential expression was highest in
AC18:0-treated cardiomyocytes compared to untreated
controls (Fig. 5e).
Discussion
The overarching objective of this work was to identify
sex differences in lipid metabolism in a NOD animal
model of T2DM. This effort was partly motivated by the
lack of adequate animal models to study sex differences
in T2DM [35]. Since gene expression alone may be in-
sufficient to address the question of sex differences in































































































































































































Fig. 4 Sex differences in AC homeostasis. a Profile of AC in cardiac tissue, as measured by LC-MS/MS, presented as fold change between NOD and
Wistar rats by sex. An asterisk (*) indicates that the fold change is statistically significant. A dagger (†) indicates that in the ANOVA model, the overall
sex difference is statistically significant. b Net ACs level in the tissue, identified by summing up individual AC species. The dagger (†) indicates that in
the ANOVA model the overall sex difference is statistically significant. c Distribution of enriched and depleted of AC moities. The asterisk (*) indicates
that the distribution is significantly different than a binomial distribution with mean = 0.5. The dagger (†) indicates that the distribution in males and
females differ significantly. d Pooled distribution of ACs based on their chain length. e Pooled distribution of ACs based degree of saturation. Data in
d and e are presented as mean ± SEM (N = 6). The asterisk (*) indicates that comparison between adjacent bars is significant. The section sign (§)
indicates that the ANOVA interaction term is significant. A dagger (†) indicates that in the ANOVA model, the overall sex difference is
statistically significant
Devanathan et al. Biology of Sex Differences  (2016) 7:25 Page 8 of 12
metabolism, we pursed a genomic-metabolomic approach
to characterize sex differences in metabolism where
changes in metabolite species are the ultimate end-
product of gene and protein expression differences. Of
note, it is well established that women generally have a
higher percentage of body fat than men [36], resulting in
increased levels of circulating FA and TGs. Since in-
creased peripheral lipid availability to the heart, as is the
case in obesity, can induce cardio-metabolic remodeling
independent of the underlying pathophysiology of dia-
betes, we hypothesized that the use of NOD animal
models of T2DM will reveal metabolic signatures of dia-
betes, in a sex-specific manner.
Unlike obese animal models of T2DM, NOD rats did not
display significant differences in circulating NEFA levels al-
though they displayed slightly elevated TG, consistent with
previous work on NOD rats [37–40]. In cardiac tissue,
NOD rats exhibited elevated steady state levels of NEFAs,
which was particularly higher in male NOD rats. Expres-
sion analysis of gene arrays involved in FA metabolism
revealed marked differences in mitochondrial beta-
oxidation, most notably preference towards FA oxidation
in male NOD rats in contrast to down-regulation of gene
involved in FA oxidation in female rats (Fig. 1). In parallel,
we observed significant sex differences in the expression
of genes involved in FA activation and AC metabolism.
Moreover, multi-dimensional PCA analysis identified sig-
nificant differences in the expression levels of a broad set
of genes regulating multiple pathways including energy
sensing, FA catabolism, acylcarnitine transport and activa-
tion, and that of TG biosynthesis and degradation. To as-



































































































































Fig. 5 Integrated lipidomics analysis of NEFA, AC, and TG and induction of ROS by ACs. a 3D score plot of first three principal components (PCs)
for metabolites obtained from PCA. b Radar plot of loading factors of principal components for lipidomic analysis. The purple line and circles
represent PC1, the brown line and circles represent PC2, the green line and circles represent PC3, and the yellow line and circle represents PC4. All
loadings were positive and hence are depicted using closed circles. c Depicted are representative confocal microscopy images of cardiomyocytes
incubated with ethanol (control) and 25 μM of AC14:0, AC16:0, and AC18:0 (bar = 50 μM). d The sum intensities of each image from the test
groups were compared with untreated cells. Averages of the image intensities, mean + SEM are shown. e Relative expression levels of genes
Sod1, Sod2, and Cat in cardiomyocytes compared to the untreated control cells. Average CT of b-actin and LdhA was used to normalize the data.
An asterisk (*) indicates that the comparison identified by the bar is significant at P < 0.05
Devanathan et al. Biology of Sex Differences  (2016) 7:25 Page 9 of 12
expression, we performed lipidomic profiling of NEFA,
TG, and AC in cardiac tissues.
Our lipidomics data suggests sex differences in TG
homeostasis. NOD female rats exhibited significantly lower
total TG concentrations than female Wistar rats, and virtu-
ally all the TG species assayed were lower in NOD females
compared with age-matched Wistar rats. While TGs have
long been proposed to adversely affect cardiac function and
physiology [16, 18], recent data suggests that TG may also
play a cardio-protective role by absorbing excess lipid sup-
ply to the heart [41, 42]. The observation that female NOD
hearts display significantly lower levels of TG may suggest
that FAs were channeled away from TG synthesis or that
TGs were converted into other lipid products such as DAG
and ceramides.
In addition to sex differences in TG metabolism, our lipi-
domic analysis also revealed sex differences in AC metabol-
ism with female rats exhibiting higher concentration of
ACs than male rats. Long-chain ACs have long ago been
documented as arrhythmogenic affecting myocyte electro-
physiology [43–45] and influencing recovery following is-
chemic injury [46, 47]. However, recent mechanistic [48,
49] and metabolomic [50–53] studies using diabetic animal
models have identified intra-mitochondrial disturbances
where lipid overload resulted in the accumulation of AC
and incomplete FA oxidation [54]. The role of AC in
T2DM has been highlighted by recent reports suggesting
that serum levels of ACs are altered in pre-diabetic condi-
tions [54, 55] and by reports identifying serum AC species
indicative of enhanced risk to T2DM and insulin resistance
[31, 56–59]. Importantly, accumulation of ACs has been
shown to interfere with insulin signaling [48, 60–63], acti-
vate pro-inflammatory signaling pathways [30], induce cel-
lular uncoupling [64], and generate cytoplasmic ROS [30]
in murine monocyte/macrophages.
In the current work, PC3 in Fig. 5c identified
AC16:0 and AC18:0 as having the most variability in
dictating sex differences in AC metabolism. To test
the feasibility of AC to induce ROS in cardiomyo-
cytes, rat cardiomyocytes were exposed to 25 μM of
AC16:0, AC18:0, and AC14:0 (the latter based on lit-
erature precedent [30]). Our results suggest that
AC18 induced over threefold higher production of
ROS than untreated cardiomyocytes, followed by
AC14:0. In parallel to increased ROS as a response to
AC stimuli, expression analysis of genes with estab-
lished roles in ROS scavenging confirmed activation
of ROS mitigating pathways. These observations dem-
onstrate, for the first time, that ACs can induce pro-
duction of ROS in cardiomyocytes. Further studies
are required to fully characterize the specificity and
selectivity of ACs in inducing cardiac ROS, insulin re-
sistance, and downstream derangements in cardio-
myocyte health and function in a sex-specific manner.
Conclusions
In summary, these observations represent the first such
report of sex differences in AC and TG metabolism as a
potential metabolic signature of diabetes, which may
contribute to downstream derangements in cardiac func-
tion in a sex-specific manner. Our analysis revealed sex
differences in the expression of a broad range of genes
involved in the metabolism of FAs, ACs, and TGs. Fur-
thermore, integrated lipidomics analysis indicated that
whereas NOD male rats exhibit enhanced oxidative me-
tabolism activity and accumulation of TG species, female
NOD rats tend to exhibit enhanced accumulation of AC
species and reduced TG compared to male rats. Finally,
we have demonstrated that ACs can induce production
of ROS in cardiomyocytes, providing a new dimension
for the observed sexual dimorphism in diabetic cardio-
vascular disease. Some of the potential implications in-
clude the following: from a therapeutic point, therapies
that minimize accumulation of ACs and potentially
other by-products of beta-oxidation may be of interest
in treating females. From an imaging standpoint, our
data suggests that currently available metabolic tracers,
in particular for positron emission tomography (PET),
may be unable to discern intrinsic (as opposed to sys-
temic) sex differences in lipid metabolism, suggesting
that new panel of metabolic PET tracers may be needed
to fully interrogate sex differences in cardiac metabolism
and downstream effects. Thus, overall, our data highlight
broad implications for therapy and diagnosis of T2DM.
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